← Leaderboards
Ian K McNiece
University Of Colorado Denver
$6,279,331
Attributed
$6,279,331
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–10$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$6,279,331 · 5
By mechanism
R01$3,591,163 · 2
U54$1,423,408 · 1
P30$954,110 · 1
R21$310,650 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Karen L Kelly$2,781,251
- Elizabeth J Shpall$12,617,686
- Edward C Dempsey$5,615,777
- Richard D Irons$1,625,034
- Carol A Kruse$3,200,645
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchTissue /Cell CultureStem Cell TransplantationClinical TrialsCell PhysiologyValidationCellsProceduresTissuesMethod DevelopmentReagent TestingResearch InfrastructureServicesScale UpBasic ScienceEnsureInvestigational New Drug ApplicationResearch PersonnelStem CellsLaboratoriesNeutrophilT LymphocyteFlow CytometryBone Marrow Transplantation
Grant awards (22)
CELLULAR THERAPY$245,950
P30 · FY2010 · CA · contact PI
CELLULAR PROCESSING CORE$278,125
U54 · FY2009 · HL · contact PI
CELLULAR THERAPY$249,331
P30 · FY2009 · CA · contact PI
CELLULAR THERAPY$98,301
P30 · FY2009 · CA · contact PI
CELLULAR PROCESSING CORE$268,238
U54 · FY2008 · HL · contact PI
CELLULAR THERAPY$120,176
P30 · FY2008 · CA · contact PI
CELLULAR PROCESSING CORE$274,457
U54 · FY2007 · HL · contact PI
CELLULAR THERAPY$120,176
P30 · FY2007 · CA · contact PI
CELLULAR PROCESSING CORE$300,781
U54 · FY2006 · HL · contact PI
CELLULAR THERAPY$120,176
P30 · FY2006 · CA · contact PI
EX VIVO EXPANDED CORD BLOOD CELLS$454,695
R01 · FY2005 · CA
A MURINE MODEL OF HEMATOPOIETIC ENGRAFTING CELLS$408,750
R01 · FY2005 · HL
CELLULAR PROCESSING CORE$301,807
U54 · FY2005 · HL
EX VIVO EXPANDED CORD BLOOD CELLS$441,452
R01 · FY2004 · CA
A MURINE MODEL OF HEMATOPOIETIC ENGRAFTING CELLS$408,750
R01 · FY2004 · HL
GRAFT REJECTION$155,325
R21 · FY2004 · CA
EX VIVO EXPANDED CORD BLOOD CELLS$428,594
R01 · FY2003 · CA
A MURINE MODEL OF HEMATOPOIETIC ENGRAFTING CELLS$408,750
R01 · FY2003 · HL
GRAFT REJECTION$155,325
R21 · FY2003 · CA
EX VIVO EXPANDED CORD BLOOD CELLS$384,297
R01 · FY2002 · CA
A MURINE MODEL OF HEMATOPOIETIC ENGRAFTING CELLS$265,493
R01 · FY2002 · HL
EX VIVO EXPANDED CORD BLOOD CELLS$390,382
R01 · FY2001 · CA